LATEST KEY DEVELOPMENTS

Competition & State Aid

• Launch of Multilateral Working Group of leading competition authorities to assess the effects of mergers in the pharmaceutical sector, including drug pricing

• European Parliament issues Study on Non-performing Loans (“NPLs”), including addressing EU State aid rules and potential surge in NPLs due to COVID-19 crisis

• EU approves new and amended Member State measures to support the economy

Trade / Export Controls

• European Commission extends export authorization mechanism for COVID-19 vaccines until 30 June 2021

• European Parliament INTA Committee meeting to discuss COVID-19 related topics

Medicines and Medical Devices

• EMA to review administration of AstraZeneca’s COVID-19 vaccine and potential related thromboembolic events

• European Commission grants conditional marketing authorization to Janssen’s single-dose COVID-19 vaccine

• EMA starts rolling review of Eli Lilly antibodies for treatment of COVID-19

Cybersecurity, Privacy & Data Protection

• European Commission issues Outline on a Trust Framework for Interoperability of health certificates